Thomas De Aguiar Vallim

Title: Innovations by Thomas De Aguiar Vallim

Introduction

Thomas De Aguiar Vallim is an accomplished inventor based in Los Angeles, California. He has made significant contributions to the field of metabolic disorders through his innovative research and patent work. His expertise lies in the identification of therapeutic targets and agents that can help in the treatment of hepatic lipid dysregulation.

Latest Patents

Thomas holds a patent for PSMD9 inhibitors for the treatment of hepatic lipid dysregulation. This patent relates to the post-genomic identification of therapeutic targets and agents. Specifically, it focuses on PSMD9 inhibitors and methods for preventing or treating metabolic disorders such as fatty liver disease, which are associated with dysregulation of lipid homeostasis.

Career Highlights

Throughout his career, Thomas has worked with notable institutions, including the Baker Heart and Diabetes Institute and the University of California. His work has been instrumental in advancing the understanding of metabolic disorders and developing potential treatments.

Collaborations

Thomas has collaborated with several professionals in his field, including Anna Christine Drew and Brian Gary Drew. These collaborations have contributed to the depth and breadth of his research.

Conclusion

Thomas De Aguiar Vallim's innovative work in the field of metabolic disorders highlights his commitment to advancing medical science. His contributions through patents and collaborations continue to pave the way for new treatments and understanding of lipid dysregulation.